Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy
Abstract Background Professional society practice guidelines conflict regarding their recommendations of dofetilide (DOF) and sotalol (STL) for treatment of arrhythmias in hypertrophic cardiomyopathy (HCM), and supporting data is sparse. We aim to assess safety and efficacy of DOF and STL on arrhyth...
| Published in: | Communications Medicine |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-07-01
|
| Online Access: | https://doi.org/10.1038/s43856-023-00315-8 |